Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
CHISEL trial: what clinicians have said so far
Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC)
- NCT01014130 ↗
- Unknown
- Trans Tasman Radiation Oncology Group
- Deep size, estimated: 301+ verified statements
We haven't built an HCP commentary report on CHISEL (inoperable stage I non-small cell lung cancer; tests a strategy, not a drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on CHISEL so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 33 posts on X | |
| 1 YouTube video | |
| 1 podcast episode |
The trial
ClinicalTrials.gov- Official title
- A Randomised Phase III Trial of Highly Conformal Hypofractionated Image Guided ("Stereotactic") Radiotherapy (HypoRT) Versus Conventionally Fractionated Radiotherapy (ConRT) for Inoperable Early Stage I Non-small Cell Lung Cancer (CHISEL)
- Phase
- Phase 3
- Status
- Unknown
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Hypofractionated radiotherapy (HypoRT); Conventionally Fractionated Radiotherapy (ConRT)
- Arms
- Arm 2 · Active comparator
- Arm 1 · Experimental
- Enrollment
- 101
- Primary outcomes
- Time to Local Failure
- Sponsor
- Trans Tasman Radiation Oncology Group
- Start
- Dec 2009
- Primary completion
- Dec 2020 (estimated)
- Results posted
- No
- Registry record
- NCT01014130 · updated Jul 12, 2017
Publications
linked from the registry- Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Vanevski M, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Shaw M, Schofield P, Irving L, Solomon B; TROG 09.02 CHISEL investigators. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol. 2019 Apr;20(4):494-503. doi: 10.1016/S1470-2045(18)30896-9. Epub 2019 Feb 12. PubMed 30770291